The correlation between ketamine-induced schizophrenia-like signs in mice and the expressions of NRG1, ErbB4 mRNA

Journal of Forensic Medicine

Volumn 25, Issue 5, 2009, Pages

  Bian, Shi Zhong ^a   Liu, Wei Li ^a   Zhang, Zhi Xiang ^a   Gu, Zhen Lun ^b,c   Jiang, Xiao Gang ^b,c   Guo, Ci Yi ^b  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Suzhou Institute of Chinese Materia Medica   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

ErbB4; Forensic psychiatry; Ketamine; Mice; NRG1; Schizophrenia

Indexed keywords

CLOZAPINE; EOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR 4; HEMATOXYLIN; KETAMINE; MESSENGER RNA; NEU DIFFERENTIATION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FORENSIC PSYCHIATRY; HIPPOCAMPUS; LOW DRUG DOSE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ANIMALS; CLOZAPINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; KETAMINE; MALE; MICE; NEUREGULIN-1; NEURONS; RANDOM ALLOCATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 72049118715     PISSN: 10045619     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1004-5619.2009.05.009     Document Type: Article

References (14)

1. Morgan CJ, Rossell SL, Pepper F, et al. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users[J]. Biol Psychiatry, 2006,59(3):265-272. (Pubitemid 43208974)
2. Corlett PR, Honey GD, Fletcher PC. From prediction error to psychosis: Ketamine as a pharmacological model of delusions[J]. J Psychopharmacol, 2007,21(3): 238-252.
3. Low SJ, Roland CL. Review of NMDA antagonist-induced neurotoxicity and implications for clinical development[J]. Int J Clin Pharmacol Ther, 2004,42(1): 1-14.
4. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs[J]. Science, 1989,244(4910):1360-1362. (T##358JS) (Pubitemid 19170513)
5. Corvin AP, Morris DW, McGhee K, et al. Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus[J]. Mol Psychiatry, 2004,9(2):208-213.
6. Buonanno A, Fischbach GD. Neuregulin and ErbB receptor signaling pathways in the nervous system[J]. Curr Opin Neurobiol, 2001,11(3):287-296. (Pubitemid 32524093)
7. Arnold SE, Talbot K, Hahn CG. Neurodevelopment, neuroplasticity, and new genes for schizophrenia[J]. Prog Brain Res, 2005,147:319-345. (Pubitemid 39582800)
8. Norton N, Moskvina V, Morris DW, et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia[J]. Am J Med Genet B Neuropsychiatr Genet, 2006,141B(1): 96-101.
9. Silberberg G, Darvasi A, Pinkas-Kramarski R, et al. The involvement of ErbB4 with schizophrenia: association and expression studies[J]. Am J Med Genet B Neuropsychiatr Genet, 2006,141B(2):142-148. (Pubitemid 43214789)
10. Hakak Y, Walker JR, Li C, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia[J]. Proc Natl Acad Sci U S A, 2001,98(8):4746-4751. (Pubitemid 32295047)
11. Hashimoto R, Straub RE, Weickert CS, et al. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia[J]. Mol Psychiatry, 2004,9(3):299-307. (Pubitemid 38496722)
12. Hahn CG, Wang HY, Cho DS, et al. Altered neuregulin1-ErbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia[J]. Nat Med,2006,12(7):824-828.